Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone

INTRODUCTION: Phosphatidylinositol 3-kinase (PI3K) pathway deregulation (that is PIK3CA mutations and/or phosphatase and tensin homolog (PTEN) loss) has been shown to enhance breast cancer cell survival and confer resistance to chemotherapeutic agents. We studied the prognostic and predictive value...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Binghe, Guan, Zhongzhen, Shen, Zhenzhou, Tong, Zhongshen, Jiang, Zefei, Yang, Junlan, DeSilvio, Michelle, Russo, Mark, Leigh, Meggan, Ellis, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187249/
https://www.ncbi.nlm.nih.gov/pubmed/25056500
http://dx.doi.org/10.1186/s13058-014-0405-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187249/
https://www.ncbi.nlm.nih.gov/pubmed/25056500
http://dx.doi.org/10.1186/s13058-014-0405-y

Ejemplares similares